Background
Allen Bickel received a Tdap vaccine after a dog bite in May 2019. Within weeks, he developed neuropathy, weakness, muscle cramps, and other symptoms; he was hospitalized in July 2019 and was later diagnosed with Guillain-Barré syndrome (GBS). He filed a Vaccine Act petition in February 2021, alleging that the vaccination caused his GBS.
Bickel supported his non-Table claim with expert opinions advancing molecular mimicry and bystander activation theories. The government’s experts disputed a causal connection and identified Bickel’s recent upper respiratory infection as a more likely trigger. Chief Special Master Corcoran denied entitlement on the first Althen causation prong, concluding that the medical science did not preponderantly support a theory that Tdap can cause GBS.
The Court’s Holding
Judge Holte granted Bickel’s motion for review, vacated the entitlement denial, and remanded. The court held that the Chief Special Master acted arbitrarily and capriciously by failing to provide a reasoned explanation connecting the denial to the evidence in this record.
The special master could draw on experience from prior Tdap-GBS cases, but could not reject Bickel’s theory solely by citing prior decisions without meaningfully analyzing the case-specific expert evidence, including the molecular-mimicry evidence and BLAST results. On remand, the special master must assess whether Bickel’s theory is reliable under Althen prong one, consider relevant evidence, draw plausible inferences, and articulate a rational basis. A new entitlement decision is due within 90 days.
Key Takeaways
- A Vaccine Act entitlement decision must explain how record evidence supports its conclusions; summarizing evidence is not enough.
- Under Althen prong one, a petitioner must offer a reliable, case-specific medical theory, not merely a plausible one.
- Prior special-master decisions may inform analysis, but they cannot replace individualized evaluation of the evidence presented.
Why It Matters
The decision reinforces that deferential review of Vaccine Program rulings still requires transparent, reviewable reasoning. Special masters must show why the evidence in the particular case does or does not support a reliable causal theory.
The ruling also addresses inconsistent outcomes in Tdap-GBS claims by emphasizing adherence to the governing Althen standard and evidence-based analysis rather than categorical reliance on prior denials.